AI assistant
JOHNSON & JOHNSON — Director's Dealing 2025
Aug 19, 2025
29750_dirs_2025-08-18_4a9a5362-397a-4e4e-9c7c-b5a8995b32d6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2025-08-15
Reporting Person: Wolk Joseph J (Exec VP, CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-08-15 | Common Stock | M | 16820 | $101.87 | Acquired | 30820 | Direct |
| 2025-08-15 | Common Stock | S | 16820 | $176.9067 | Disposed | 14000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-15 | Employee Stock Options (Right to Buy) | $101.87 | M | 16820 | Disposed | 2026-02-08 | Common Stock (16820) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 68835 | Indirect |
| Common Stock | 2145 | Indirect |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $176.87 to $177.015. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Held in a spousal lifetime access trust, of which the reporting person's spouse is the trustee and beneficiary.
F3: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (7/31/2025).
F4: Vested and exercisable one day after the third anniversary of the date of the grant.